3.4. NKX3.1 Overexpression Is Sufficient to Promote Growth During Androgen Depletion and AR-Antagonization in Enzalutamide-Naïve Prostate Cancer Cells and Upregulates Selective Response Element (sARE) Regulated AR Target Genes. The gene discussed is AR; the disease is prostate carcinoma.